The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*

AIM OF THE STUDY: was to analyze the outcome of treatment and factors predicting results of sorafenib therapy in inoperable/metastatic CD117-positive GIST patients after failure on imatinib and sunitinib. MATERIAL AND METHODS: We identified 60 consecutive patients (40 men, 20 women) with advanced in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutkowski, Piotr, Jagielska, Beata, Andrzejuk, Jolanta, Bylina, Elzbieta, Lugowska, Iwona, Switaj, Tomasz, Kosela-Paterczyk, Hanna, Kozak, Katarzyna, Falkowski, Slawomir, Klimczak, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798420/
https://www.ncbi.nlm.nih.gov/pubmed/29416434
http://dx.doi.org/10.5114/wo.2017.72393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798420/
https://www.ncbi.nlm.nih.gov/pubmed/29416434
http://dx.doi.org/10.5114/wo.2017.72393

Ejemplares similares